ABT - Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price
2024-07-07 03:22:56 ET
Summary
- The S&P 500 gained 2% last week despite weak employment data and manufacturing sentiment, driven by optimism about potential Fed rate cuts.
- Abbott Laboratories, though lagging the S&P 500, shows promise with diversified growth in diagnostics, nutrition, diabetes care, and heart health.
- With a strong dividend and innovation-driven outlook, Abbott is well-positioned for long-term gains, although current high valuations suggest cautious optimism.
Introduction
Bloomberg hit the nail on the head when it wrote : "High-Priced S&P 500 Powers Head Untroubled by Political Stress."
Essentially, the market went back to doing what it does best, which is betting on the Fed easing rates going forward. This allowed it to ignore poor employment numbers, construction in the services industry, and weakness in manufacturing sentiment....
Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price